Explore Our Comprehensive Pharmaceuticals Industry Research Reports
U
2024
Due to factors such as rapid urbanization and globalization, human health is being adversely affected. Hypertension is a serious health condition that increases the risk of coronary heart ...
Report Code : A03354 | Category : Life Sciences
U
2024
Pulmonary hypertension is a state of the body in which the blood pressure rises in the arteries. Pulmonary hypertension drugs belong to the class of anti-hypertensives drugs that ...
Report Code : A03661 | Category : Life Sciences
P
2022
The global pulmonary arterial hypertension treatment market was valued at $7,177.81 million in 2021, and is projected to reach $11,968.60 million by 2031, growing at a CAGR of 5.2% from 2021 to 2031.
Report Code : A05105 | Pages : 335 | Category : Life Sciences
P
2023
In market Drug Type, Prostacyclin and Prostacyclin Analogs holds the largest revenue share during the analysis period and Drug Type is expected to exhibit the highest CAGR over the analysis period.
Report Code : A188234 | Pages : 77 | Category : Life Sciences
P
2023
The Mexico Pulmonary Arterial Hypertension Treatment Market report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the key ...
Report Code : A188235 | Pages : 73 | Category : Life Sciences
P
2023
The Europe Pulmonary Arterial Hypertension Treatment Market is expected to grow lucratively over the forecast period. In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies.
Report Code : A188236 | Pages : 122 | Category : Life Sciences
P
2023
The Germany Pulmonary Arterial Hypertension Treatment Market study provides detailed analysis on major drivers, restraints, trends, opportunities, and key player strategies impacting overall performance of market throughout the forecast period.
Report Code : A188237 | Pages : 80 | Category : Life Sciences
P
2023
The Drug Type has the highest CAGR over the analysis period. The section Top Winning Strategies from report provides insights about most frequently adopted strategies by key players in the market.
Report Code : A188238 | Pages : 75 | Category : Life Sciences
P
2023
In market Drug Type, Prostacyclin and Prostacyclin Analogs holds the largest revenue share during the analysis period and Drug Type is expected to exhibit the highest CAGR over the analysis period.
Report Code : A188239 | Pages : 87 | Category : Life Sciences
P
2023
The Italy Pulmonary Arterial Hypertension Treatment Market achieved significant revenue share in base year of analysis. The Italy Pulmonary Arterial Hypertension Treatment Market size is expected to account for a considerable growth rate between 2021 to 2031.
Report Code : A188240 | Pages : 72 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.